Cardiac Autonomic Modulation focuses on therapies that target the sympathetic and parasympathetic nervous systems to influence heart rate, rhythm, and hemodynamics. This session explores emerging neuromodulatory strategies such as renal denervation, baroreflex activation, and vagal stimulation, alongside more established approaches like beta-blockade and heart rate control. Participants will examine how autonomic imbalance contributes to hypertension, arrhythmias, and heart failure, and how targeted interventions can restore more favorable neurocardiac dynamics.

As interest grows in device-based autonomic therapies, many professionals seek a cardiology conference to understand mechanisms, trial data, and patient selection. This session reviews evidence from key studies in resistant hypertension, heart failure, and arrhythmia control, highlighting both promising results and areas of uncertainty. Attendees will learn how procedural techniques, patient characteristics, and endpoints differ among neuromodulation modalities. The discussion emphasizes realistic expectations, supporting clinicians in counseling patients about risks, benefits, and current evidence gaps.

A central theme is how neuromodulation therapies integrate with pharmacologic treatment and lifestyle modification. Participants will explore how autonomic interventions are positioned within stepwise care pathways, rather than replacing established therapies. The session addresses multidisciplinary collaboration between cardiologists, electrophysiologists, hypertension specialists, and interventionalists, along with considerations around cost, access, and health-system implementation. Practical topics such as follow-up protocols, device monitoring, and assessment of treatment response are woven into real-world case examples.

Future directions are an important focus, including novel targets for autonomic control, minimally invasive approaches, and the potential for personalized neuromodulation based on autonomic profiling. Attendees will consider how digital tools, wearable sensors, and AI-based analytics may enhance measurement of autonomic tone and guide therapy optimization. By the end, participants will appreciate the current and evolving landscape of cardiac autonomic modulation and how to integrate these therapies thoughtfully in clinical practice.